GEN Exclusives

More »

GEN News Highlights

More »
May 20, 2014

Merck Targets Italian Production Site for Investment

  • Merck KGaA plans to invest €50 million ($68.5 million) in its Italian pharmaceutical and biotech production site in Bari, Italy. The new facility in Bari is to be commissioned in 2017 for the sterile filling and packaging of liquid drugs into syringes, vials, and ampoules.

    Within Merck Serono’s global biotech production network, the Bari site is part of fill & finish operations alongside the facilities in Darmstadt, Germany, and Aubonne, Switzerland. According to Merck officials, the drugs produced within this global network are seeing long-term growing demand, especially those that treat infertility.

    “To make Merck fit for the future, we are investing in modern, expanded production capacities,” said Karl-Ludwig Kley, chairman of the executive board of Merck, making reference to the company’s “Fit for 2018” transformation and growth program. 


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Mindclones and Immortality

Is the idea of making a software copy of a human mind something in the realm of reality or science fiction?